The Vancouver-based company uses generative AI to create biologic drugs, with 20 “active programs” underway, many of them ...

Humacyte has priced the product at $29,500 per unit. This is more expensive than the synthetic vessels already on the market.

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

By fusing circular dichroism with high-resolution microspectroscopy and microscopic imaging, this cutting-edge technology is ...

Sam Finn, a senior research associate at Zymo Research working with the Oncology Diagnostic Team, helped to host this interactive game booth at the “BioFestival” on Tuesday.

Biomedical engineers at Duke University have demonstrated a new synthetic approach that turbocharges bacteria into producing ...

Synthetic cells that look just like natural cells but are chemically reversed could outcompete other living organisms − with ...

Synthetic biologists from Yale were able to re-write the genetic code of an organism - a novel genomically recoded organism (GRO) with one stop codon - using a cellular platform that they developed ...

A team of scientists from the Institute of Bio- and Geosciences–Biotechnology at Forschungszentrum Jülich worked together with the company Novonesis to develop a bacterium that "eats" individual ...

A biomaterial that can mimic certain behaviors within biological tissues could advance regenerative medicine, disease modeling, soft robotics and more, according to researchers.

Synthetic biologists from Yale were able to re-write the genetic code of an organism—a novel genomically recoded organism ...